Please login to the form below

Not currently logged in
Email:
Password:

F2G

This page shows the latest F2G news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • AstraZeneca’s John Rex joins UK biotech F2G AstraZeneca’s John Rex joins UK biotech F2G

    John Rex has moved from AstraZeneca to F2G to become the Manchester, UK-based drug discovery firm's chief medical officer. ... new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials.

  • F2G appoints chief financial officer F2G appoints chief financial officer

    Ralf Schmid brings experience from Nabriva Therapeutics. Manchester-based F2G Ltd has appointed Ralf Schmid as its new chief financial officer. ... Ian Nicholson, chief executive of F2G, said: “Following our successful $60m financing, I am delighted to

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...